| Name | Tolson Drug Inc |
|---|---|
| Organization Name | Tolson Drug Company Inc |
| Location | 226 E High St, Jefferson City, Missouri 65101 |
| Type | Pharmacy |
| Phone | (573) 636-3414 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Ben R. Leedle, Jr., president and chief executive officer of Healthways, Inc., today announced financial results for the fourth quarter and year ended December 31, 2013. Total revenues for the quarter were $169.2 million compared with $175.2 million for the fourth quarter of 2012.
A new study published online on the preprint server medRxiv in May 2020 reports that specific changes in the way the human immune system responds to COVID-19 determine whether the individual develops moderate or severe illness.
Modulating immune response to injury could accelerate the regeneration of severed peripheral nerves, a new study in an animal model has found. By altering activity of the macrophage cells that respond to injuries, researchers dramatically increased the rate at which nerve processes regrew.
Novadaq Technologies has announced that Dr. Giovanni Staurenghi, (Associate Professor of Ophthalmology, Department of Otorhinolaryngological and Ophthalmological Science University of Milan, Italy), reported preliminary data on 24-patients in an on-going study using the Company's proprietary technology to treat wet Age-Related Macular Degeneration (AMD).
A team of researchers aimed to determine the differential health effects of COVID-19 on disadvantaged population groups. They found that low-income and Black and Pardo communities in the country are more likely to die from COVID-19.
› Verified 8 days ago
| NPI Number | 1174531347 |
| Organization Name | TOLSON DRUG COMPANY, INC. |
| Type | Pharmacy |
| Address | 226 E. High St, Jefferson City, MO 65101 |
| Phone Number | 573-636-4022 |
News Archive
Ben R. Leedle, Jr., president and chief executive officer of Healthways, Inc., today announced financial results for the fourth quarter and year ended December 31, 2013. Total revenues for the quarter were $169.2 million compared with $175.2 million for the fourth quarter of 2012.
A new study published online on the preprint server medRxiv in May 2020 reports that specific changes in the way the human immune system responds to COVID-19 determine whether the individual develops moderate or severe illness.
Modulating immune response to injury could accelerate the regeneration of severed peripheral nerves, a new study in an animal model has found. By altering activity of the macrophage cells that respond to injuries, researchers dramatically increased the rate at which nerve processes regrew.
Novadaq Technologies has announced that Dr. Giovanni Staurenghi, (Associate Professor of Ophthalmology, Department of Otorhinolaryngological and Ophthalmological Science University of Milan, Italy), reported preliminary data on 24-patients in an on-going study using the Company's proprietary technology to treat wet Age-Related Macular Degeneration (AMD).
A team of researchers aimed to determine the differential health effects of COVID-19 on disadvantaged population groups. They found that low-income and Black and Pardo communities in the country are more likely to die from COVID-19.
› Verified 8 days ago
News Archive
Ben R. Leedle, Jr., president and chief executive officer of Healthways, Inc., today announced financial results for the fourth quarter and year ended December 31, 2013. Total revenues for the quarter were $169.2 million compared with $175.2 million for the fourth quarter of 2012.
A new study published online on the preprint server medRxiv in May 2020 reports that specific changes in the way the human immune system responds to COVID-19 determine whether the individual develops moderate or severe illness.
Modulating immune response to injury could accelerate the regeneration of severed peripheral nerves, a new study in an animal model has found. By altering activity of the macrophage cells that respond to injuries, researchers dramatically increased the rate at which nerve processes regrew.
Novadaq Technologies has announced that Dr. Giovanni Staurenghi, (Associate Professor of Ophthalmology, Department of Otorhinolaryngological and Ophthalmological Science University of Milan, Italy), reported preliminary data on 24-patients in an on-going study using the Company's proprietary technology to treat wet Age-Related Macular Degeneration (AMD).
A team of researchers aimed to determine the differential health effects of COVID-19 on disadvantaged population groups. They found that low-income and Black and Pardo communities in the country are more likely to die from COVID-19.
› Verified 8 days ago
Aerocare Home Medical Equipment Inc Type: Medicare Supplier Location: 4742b Country Club Dr, Jefferson City, Missouri 65109 Phone: (573) 761-5941 | |
Becvar Optometry Llc Type: Eyewear Supplier (Equipment, not the service) Location: 823 Eastland Dr, Jefferson City, Missouri 65101 Phone: (573) 893-4223 | |
Bodenhamer Eye Consultants, Llc Type: Medicare Supplier Location: 3238 W Truman Blvd, Jefferson City, Missouri 65109 Phone: (573) 635-2020 | |
Central Missouri Eyecare Associates Type: Medicare Supplier Location: 1445 Christy Dr, Jefferson City, Missouri 65101 Phone: (573) 659-5560 | |
Gerbes Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2805 W Truman Blvd, Jefferson City, Missouri 65109 Phone: (573) 893-2226 |